729 related articles for article (PubMed ID: 8051411)
1. Immunization of BALB/c mice with recombinant simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells. An antibody-based mechanism for tumor immunity.
Bright RK; Shearer MH; Kennedy RC
J Immunol; 1994 Sep; 153(5):2064-71. PubMed ID: 8051411
[TBL] [Abstract][Full Text] [Related]
2. Comparison of humoral immune responses and tumor immunity in mice immunized with recombinant SV40 large tumor antigen and a monoclonal anti-idiotype.
Shearer MH; Bright RK; Kennedy RC
Cancer Res; 1993 Dec; 53(23):5734-9. PubMed ID: 7694794
[TBL] [Abstract][Full Text] [Related]
3. Protection against a lethal challenge with SV40-transformed cells by the direct injection of DNA-encoding SV40 large tumor antigen.
Bright RK; Beames B; Shearer MH; Kennedy RC
Cancer Res; 1996 Mar; 56(5):1126-30. PubMed ID: 8640771
[TBL] [Abstract][Full Text] [Related]
4. Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cells.
Utermöhlen O; Schulze-Garg C; Warnecke G; Gugel R; Löhler J; Deppert W
J Virol; 2001 Nov; 75(22):10593-602. PubMed ID: 11602701
[TBL] [Abstract][Full Text] [Related]
5. Role of a subdominant H-2Kd-restricted SV40 tumor antigen cytotoxic T lymphocyte epitope in tumor rejection.
Newmaster RS; Mylin LM; Fu TM; Tevethia SS
Virology; 1998 May; 244(2):427-41. PubMed ID: 9601511
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy of SV40 induced tumours in mice: a model for vaccine development.
Bright RK; Shearer MH; Pass HI; Kennedy RC
Dev Biol Stand; 1998; 94():341-53. PubMed ID: 9776255
[TBL] [Abstract][Full Text] [Related]
7. Immunization of mice with baculovirus-derived recombinant SV40 large tumour antigen induces protective tumour immunity to a lethal challenge with SV40-transformed cells.
Shearer MH; Bright RK; Lanford RE; Kennedy RC
Clin Exp Immunol; 1993 Feb; 91(2):266-71. PubMed ID: 7679059
[TBL] [Abstract][Full Text] [Related]
8. Protective immunity in BALB/c mice against the simian virus 40-induced mKSA tumor resulting from injection of recombinant large T antigen. Requirement of CD8+ T lymphocytes.
Zerrahn J; Utermöhlen O; Warnecke G; Deppert W; Lehmann-Grube F
J Immunol; 1996 May; 156(10):3919-24. PubMed ID: 8621931
[TBL] [Abstract][Full Text] [Related]
9. CD4+ T lymphocytes play a critical role in antibody production and tumor immunity against simian virus 40 large tumor antigen.
Kennedy RC; Shearer MH; Watts AM; Bright RK
Cancer Res; 2003 Mar; 63(5):1040-5. PubMed ID: 12615720
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal anti-idiotypic antibodies induce humoral immune responses specific for simian virus 40 large tumor antigen in mice.
Shearer MH; Lanford RL; Kennedy RC
J Immunol; 1990 Aug; 145(3):932-9. PubMed ID: 1695650
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-4 impairs granzyme-mediated cytotoxicity of Simian virus 40 large tumor antigen-specific CTL in BALB/c mice.
Baschuk N; Utermöhlen O; Gugel R; Warnecke G; Karow U; Paulsen D; Brombacher F; Krönke M; Deppert W
Cancer Immunol Immunother; 2007 Oct; 56(10):1625-36. PubMed ID: 17431618
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity of simian virus 40-transformed C57BL/6 mouse embryo fibroblasts to lysis by murine natural killer cells.
Fresa KL; Karjalainen HE; Tevethia SS
J Immunol; 1987 Feb; 138(4):1215-20. PubMed ID: 3027174
[TBL] [Abstract][Full Text] [Related]
13. Immunization with soluble simian virus 40 large T antigen induces a specific response of CD3+ CD4- CD8+ cytotoxic T lymphocytes in mice.
Schirmbeck R; Zerrahn J; Kuhröber A; Kury E; Deppert W; Reimann J
Eur J Immunol; 1992 Mar; 22(3):759-66. PubMed ID: 1312473
[TBL] [Abstract][Full Text] [Related]
14. In vitro simian virus 40 large tumor antigen expression correlates with differential immune responses following DNA immunization.
Lowe DB; Shearer MH; Tarbox JA; Kang HS; Jumper CA; Bright RK; Kennedy RC
Virology; 2005 Feb; 332(1):28-37. PubMed ID: 15661138
[TBL] [Abstract][Full Text] [Related]
15. DNA vaccination primes MHC class I-restricted, simian virus 40 large tumor antigen-specific CTL in H-2d mice that reject syngeneic tumors.
Schirmbeck R; Böhm W; Reimann J
J Immunol; 1996 Oct; 157(8):3550-8. PubMed ID: 8871655
[TBL] [Abstract][Full Text] [Related]
16. Inability of antiserum active in antibody-dependent cellular cytotoxicity and arming tests to protect against simian virus 40 tumor cell challenge.
Prather SO; Geller RW; Lausch RN
J Natl Cancer Inst; 1979 May; 62(5):1273-7. PubMed ID: 220449
[TBL] [Abstract][Full Text] [Related]
17. Naturally occurring cell-mediated cytotoxicity against simian virus 40-transformed 3T3 murine tumor cells.
Kanar MC; Winkelstein A; Platt D
J Natl Cancer Inst; 1983 Feb; 70(2):267-73. PubMed ID: 6296520
[TBL] [Abstract][Full Text] [Related]
18. The role of gamma interferon in DNA vaccine-induced tumor immunity targeting simian virus 40 large tumor antigen.
Aldrich JF; Shearer MH; Lowe DB; Winn RE; Jumper CA; Kennedy RC; Bright RK
Cancer Immunol Immunother; 2013 Feb; 62(2):371-82. PubMed ID: 22926061
[TBL] [Abstract][Full Text] [Related]
19. In vitro studies on the cellular immune response of tumor-bearing mice to SV40-transformed cells.
Blasecki JW; Tevethia SS
J Immunol; 1975 Jan; 114(1 Pt 1):244-9. PubMed ID: 163278
[TBL] [Abstract][Full Text] [Related]
20. Cell-mediated immunity to leukemia virus- and tumor-associated antigens in mice.
Herberman RB; Holden HT; Ting CC; Lavrin DL; Kirchner H
Cancer Res; 1976 Feb; 36(2 pt 2):615-21. PubMed ID: 56223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
